Abstract
The Connectivity Map (CMAP) project profiled human cancer cell lines exposed to a library of anticancer compounds with the goal of connecting cancer with underlying genes and potential treatments. As most targeted anticancer therapeutics aim to induce tumor-selective apoptosis, it is critical to understand the specific cell death pathways triggered by drugs. This can help to better understand the mechanism of how cancer cells respond to chemical stimulations and improve the treatment of human tumors. In this study, using Connectivity MAP microarray-based gene expression data, we applied a Bayesian network modeling approach and identified apoptosis as a major drug-induced cellular pathway. We focused on 13 apoptotic genes that showed significant differential expression across all drug-perturbed samples to reconstruct the apoptosis network. In our predicted subnetwork, 9 out of 15 high-confidence interactions were validated in literature, and our inferred network captured two major cell death pathways by identifying BCL2L11 and PMAIP1 as key interacting players for the intrinsic apoptosis pathway, and TAXBP1 and TNFAIP3 for the extrinsic apoptosis pathway. Our inferred apoptosis network also suggested the role of BCL2L11 and TNFAIP3 as “gateway” genes in the drug-induced intrinsic and extrinsic apoptosis pathways.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313:1929–1935
Lamb J (2007) The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 7:54–60
Lander ES (1999) Array of hope. Nat Genet 21:3–4
Sellers WR, Fisher DE (1999) Apoptosis and cancer drug targeting. J Clin Invest 104:1655–1661
Montero-Melendez T, Dalli J, Perretti M (2013) Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors. Cell Death Differ 20:567–575
Cheng J, Xie Q, Kumar V, Hurle M, Freudenberg JM, Yang L, Agarwal P (2013) Evaluation of analytical methods for connectivity map data. Pac Symp Biocomput:5–16
Qu XA, Rajpal DK (2012) Applications of Connectivity Map in drug discovery and development. Drug Discov Today 17:1289–1298
Zimmer M, Lamb J, Ebert BL, Lynch M, Neil C, Schmidt E, Golub TR, Iliopoulos O (2010) The connectivity map links iron regulatory protein-1-mediated inhibition of hypoxia-inducible factor-2a translation to the anti-inflammatory 15-deoxy-delta12,14-prostaglandin J2. Cancer Res 70:3071–3079
Wang K, Sun J, Zhou S, Wan C, Qin S, Li C, He L, Yang L (2013) Prediction of drug-target interactions for drug repositioning only based on genomic expression similarity. PLoS Comput Biol 9:e1003315
Sandmann T, Kummerfeld SK, Gentleman R, Bourgon R (2014) gCMAP: user-friendly connectivity mapping with R. Bioinformatics 30:127–128
Adams JM (2003) Ways of dying: multiple pathways to apoptosis. Genes Dev 17:2481–2495
Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26:1324–1337
Green D (2011) Means to an end: apoptosis and other cell death mechanisms. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Wu ZJ, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F (2004) A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 99:909–917
Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:3
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25–29
Friedman N, Linial M, Nachman I, Pe’er D (2000) Using Bayesian networks to analyze expression data. J Comput Biol 7:601–620
Pe’er D, Regev A, Elidan G, Friedman N (2001) Inferring subnetworks from perturbed expression profiles. Bioinformatics 17(Suppl 1):S215–S224
Friedman N (2004) Inferring cellular networks using probabilistic graphical models. Science 303:799–805
Pe’er D (2005) Bayesian network analysis of signaling networks: a primer. Sci STKE 2005:pl4
Ellis B, Wong WH (2008) Learning causal Bayesian network structures from experimental data. J Am Stat Assoc 103:778–789
Bøttcher S (2001) Learning Bayesian networks with mixed variables. In: Proceedings of the eighth international workshop in artificial intelligence and statistics
Geiger D, Heckerman D (1994) Learning Gaussian networks. Technical Report MSRTR-94–10, Microsoft Research
Heckerman D, Geiger D, Chickering D (1995) Learning Bayesian networks: the combination of knowledge and statistical data. Mach Learn 20:197
Chickering D (1996) Learning Bayesian networks is NP-complete. In: Fisher DF, Lenz H-J (eds) Learning from data: artificial intelligence and statistics, V. Springer, New York
Bøttcher S, Dethlefsen C (2003) Deal: a package for learning Bayesian networks. J Stat Softw 8(20):1–40
Bøttcher S, Dethlefsen C (2003) Learning Bayesian networks with R. In: Hornik K, Leisch F, Zeileis A (eds) Proceedings of the 3rd international workshop on distributed statistical computing. ISSN 1609-395X
Efron B, Tibshirani R (1993) An introduction to the bootstrap. Chapman & Hall, London
Friedman N, Goldszmidt M, Wyner A (1999) Data analysis with Bayesian networks: a bootstrap approach. In: Proceedings of the Fifteenth Annual Conference on Uncertainty in Artificial Intelligence. Morgan Kaufmann, San Francisco, CA, pp 206–215
Wang CY, Mayo MW, Baldwin AS Jr (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274:784–787
http://www.ncbi.nlm.nih.gov/gene/8887
Beyaert R, De Valck D, Jin DY, Heyninck K, Van de Craen M, Contreras R, Fiers W, Jeang KT (1999) The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases. Oncogene 18:4182–4190
Beyaert R, Klinkenberg M, Van Huffel S, Heyninck K (2001) Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappa B activation and protein-protein interactions. FEBS Lett 498:93–97
Shembade N, Ma A, Harhaj EW (2010) Inhibition of NF-kappa B signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327:1135–1139
http://www.uniprot.org/uniprot/Q13794
http://thebiogrid.org/111379/summary/homo-sapiens/pmaip1.html
http://thebiogrid.org/115335/summary/homo-sapiens/bcl2l11.html
Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ, Adams JM, Strasser A (2003) p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 302:1036–1038
Villunger A, Erlacher M, Michalak EM, Kelly PN, Labi V, Niederegger H, Coultas L, Adams JM, Strasser A (2005) BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 106:4131–4138
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Yu, J., Silva, J.M. (2018). Bayesian Network to Infer Drug-Induced Apoptosis Circuits from Connectivity Map Data. In: Raghavachari, N., Garcia-Reyero, N. (eds) Gene Expression Analysis. Methods in Molecular Biology, vol 1783. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7834-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7834-2_18
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7833-5
Online ISBN: 978-1-4939-7834-2
eBook Packages: Springer Protocols